tiprankstipranks
Trending News
More News >
Oncolys BioPharma, Inc. (JP:4588)
:4588
Japanese Market

Oncolys BioPharma, Inc. (4588) Financial Statements

Compare
0 Followers

Oncolys BioPharma, Inc. Financial Overview

Oncolys BioPharma, Inc.'s market cap is currently ¥15.28B. The company's EPS TTM is ¥-32.66; its P/E ratio is ―; Oncolys BioPharma, Inc. is scheduled to report earnings on May 9, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 31.38M¥ 63.04M¥ 976.18M¥ 642.49M¥ 314.18M
Gross Profit¥ 31.38M¥ 30.61M¥ 338.49M¥ 198.80M¥ 236.11M
Operating Income¥ -1.68B¥ -1.93B¥ -1.20B¥ -1.45B¥ -1.67B
EBITDA¥ -1.68B¥ -1.93B¥ -1.14B¥ -1.60B¥ -2.08B
Net Income¥ -1.68B¥ -1.94B¥ -1.15B¥ -1.62B¥ -2.10B
Balance Sheet
Cash & Short-Term Investments¥ 2.41B¥ 1.53B¥ 1.71B¥ 3.45B¥ 2.07B
Total Assets¥ 3.20B¥ 2.04B¥ 2.65B¥ 4.29B¥ 2.80B
Total Debt¥ 324.64M¥ 315.17M¥ 393.66M¥ 503.47M¥ 525.08M
Net Debt¥ -1.84B¥ -972.59M¥ -1.32B¥ -2.95B¥ -1.54B
Total Liabilities¥ 446.65M¥ 566.50M¥ 491.69M¥ 697.88M¥ 793.09M
Stockholders' Equity¥ 2.75B¥ 1.47B¥ 2.16B¥ 3.59B¥ 2.00B
Cash Flow
Free Cash Flow¥ -2.02B¥ -1.34B¥ -1.72B¥ -1.74B¥ -1.47B
Operating Cash Flow¥ -2.02B¥ -1.34B¥ -1.72B¥ -1.74B¥ -1.47B
Investing Cash Flow¥ -4.71M¥ -5.39M¥ 20.12M¥ -942.00K¥ -37.58M
Financing Cash Flow¥ 2.88B¥ 1.14B¥ -113.83M¥ 3.09B¥ 242.26M
Currency in JPY

Oncolys BioPharma, Inc. Earnings and Revenue History

Oncolys BioPharma, Inc. Debt to Assets

Oncolys BioPharma, Inc. Cash Flow

Oncolys BioPharma, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis